IgAN/FSGS Monitoring Roundtable | Q2 2026
This educational material was developed by independent expert faculty. Sponsors providing unrestricted educational support had no role in faculty selection, content development, conclusions, or dissemination.
Prioritized open questions in IgAN/FSGS monitoring and, for each, the type of evidence that would materially reduce uncertainty (e.g., prospective data, validation in specific populations, workflow studies).
Areas of disagreement or uncertainty are explicitly preserved and labeled. Non-consensus is a valid outcome. This material does not provide treatment recommendations.
Content forthcoming
Expected ~60-90 days post-session
Monitoring Cadence Map + Evaluation Decision Points (~30-day)